Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet. Haematology
View this publicationThe Lancet. Haematology
View this publicationJournal of functional biomaterials
View this publicationBiology direct
View this publicationPublication categories: Top publication
Nucleic acids research
View this publicationRadiologie (Heidelberg, Germany)
View this publicationScientific reports
View this publicationFrontiers in bioengineering and biotechnology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationJournal of nuclear medicine : official publication, Society of Nuclear Medicine
View this publicationDermatologie (Heidelberg, Germany)
View this publication